CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) Mechanical circulatory support devices in advanced heart failure: 2020 and beyond Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Antithrombotics From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5) Dilated cardiomyopathy: so many cardiomyopathies! The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure

JOURNAL: Article Link

南京市第一医院心血管内科为多名复杂性肺高压患者实施肺血管介入治疗

qiaomingyue Keywords: 近年来,肺动脉高压在病理机制、诊断、风险评估及治疗等方面有诸多新进展,治疗策略不断更新,交感神经学说在肺动脉高压发生及发展中起着重要作用。经皮肺动脉去神经术(percutaneous pulmonary artery denervation,PADN)由陈绍良教授创新发明并成功开展后,越来越多的研究证据均显示其良好的疗效及广阔的前景,随着这一技术在全球的普及,肺动脉高压的治疗已经迈入在靶向药物治疗基础上的介入治疗新时代。

网站资料更新中...